Newsroom | 5488 results

Sorted by: Latest

Alternative Medicine
-

Brightseed Launches BioMetaControl™, a Nature-Inspired GLP-1 Companion for Metabolic Health

SAN FRANCISCO--(BUSINESS WIRE)--Powered by Forager® AI from discovery to market, Brightseed Launches BioMetaControl™, a Nature-Inspired GLP-1 Companion for Metabolic Health....
-

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy

LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for eligible transfusion-dependent beta thalassemia (TDT) and severe sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). “Today is a turning point for eligible people in Italy living with transfusion-dependent beta thalassemia and sickle cell disease, two life-shortening diseases with...
-

New Public Service Campaign Encourages Eye Exams to Save Sight

CLARKSBURG, Md.--(BUSINESS WIRE)--BrightFocus Foundation launches two national public service announcements encouraging eye exams to save sight from macular degeneration and glaucoma....
-

Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on September 16, 2025. At the Meeting, the number of directors of the Company for the ensuing year was fixed at seven (7) and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represe...
-

ProCare Injury Specialists Expands Texas Presence with New Temple Clinic

TEMPLE, Texas--(BUSINESS WIRE)--ProCare Injury Specialists today announced the opening of its newest clinic in Temple, Texas – marking its 11th clinic statewide....
-

I2Pure Celebrates Achievements of Medical Advisors Dr. John Meehan and Dr. Peter Johnston

ASHBURN, Va.--(BUSINESS WIRE)--I2Pure, an emerging biotech company focused on developing and marketing novel iodine formulations for healthcare and industrial biosafety applications, is proud to celebrate the achievements of two of its valued medical advisors, Dr. John Meehan and Dr. Peter Johnston. Drs. Meehan’s and Johnston’s continued excellence in orthopedic surgery and dedication to advancing infection prevention science exemplifies the caliber of expertise that guides I2Pure's mission to...
-

フリースランド・カンピーナ・イングリーディエンツ、シンガポールに最新鋭のアプリケーションセンターを開設し、研究開発(R&D)機能を強化

シンガポール--(BUSINESS WIRE)--(ビジネスワイヤ) -- タンパク質およびプレバイオティクスの世界的リーダーであるフリースランド・カンピーナ・イングリーディエンツ(FrieslandCampina Ingredients)は、このたびシンガポールに新たなアプリケーションセンターを開設したことを発表しました。この開設により、同国におけるR&Dスペースは30%拡大することとなります。同施設はシンガポール経済開発庁(EDB)の支援を受けており、日本、韓国、オーストラリア、ニュージーランド、東南アジアを含む、変化を遂げているアジア太平洋(APAC)市場への戦略的ゲートウェイとして機能します。拡張されたアプリケーションセンターは、シンガポールが同社にとって重要な地域本部であることを改めて示すだけでなく、地域の多様かつ拡大する栄養ニーズに応えるため、ブランド向けにカスタマイズされた原料ソリューションをより迅速に提供できるようにします。シンガポールには、フリースランド・カンピーナ・プロフェッショナル(FrieslandCampina Professional)やフリースラ...
-

AESARA Welcomes Industry Veteran Anita Brogan as VP of Modeling and Communications

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a leading digital-forward Value & Access agency, today announced the appointment of Anita Brogan, PhD, as Vice President, Value & Evidence - Modeling and Communications within its Value and Evidence team. With over 20 years of experience designing and building economic analyses to support value assessment and patient access for innovative healthcare interventions, Anita brings deep expertise in both global...
-

FrieslandCampina Ingredients在新加坡新建先進應用中心,擴大研發能力

新加坡--(BUSINESS WIRE)--(美國商業資訊)-- 蛋白質和益生元領域的全球領導者FrieslandCampina Ingredients宣布在新加坡設立新的應用中心,使該公司在新加坡的研發空間增加了30%。在新加坡經濟發展局(EDB)的支援下,該設施將成為針對不斷發展的亞太市場(包括日本、韓國、澳洲、紐西蘭和東南亞)的策略門戶。新擴建的應用中心不僅重申了新加坡做為公司重要地區總部的地位,還有助於更快地提供客製化配料解決方案,協助品牌滿足該地區多樣化且不斷成長的營養需求。新加坡也是FrieslandCampina其他業務集團的所在地,包括FrieslandCampina Professional和FrieslandCampina Asia,彰顯了公司對該市場的長期承諾。 推動以亞太為中心的創新 由於亞太地區五分之四的消費者積極服用營養補充品1,該地區不斷成長的需求為以消費者為中心的應用開發提供了巨大商機。新的應用中心強化了FrieslandCampina Ingredients在亞太地區的實地應用和技術專長,以滿足這一需求。該中心配備了先進的實驗室,用於開發優格、能量棒和...
-

FrieslandCampina Ingredients在新加坡新建先进应用中心,拓展研发能力

新加坡--(BUSINESS WIRE)--(美国商业资讯)-- 蛋白质和益生元领域的全球领导者FrieslandCampina Ingredients宣布在新加坡开设新的应用中心,使该公司在新加坡的研发空间增加了30%。在新加坡经济发展局(EDB)的支持下,该设施将成为面向不断发展的亚太市场(包括日本、韩国、澳大利亚、新西兰和东南亚)的战略门户。新扩建的应用中心不仅重申了新加坡作为公司重要地区总部的地位,还有助于更快地提供定制化配料解决方案,帮助品牌满足该地区多样化且不断增长的营养需求。新加坡也是FrieslandCampina其他业务集团的所在地,包括FrieslandCampina Professional和FrieslandCampina Asia,凸显了公司对该市场的长期承诺。 推动以亚太为中心的创新 由于亚太地区五分之四的消费者积极服用营养补充剂1,该地区不断增长的需求为以消费者为中心的应用开发提供了巨大机遇。新的应用中心加强了FrieslandCampina Ingredients在亚太地区的实地应用和技术专长,以满足这一需求。该中心配备了先进的实验室,用于开发酸奶、能量...